Regulation
Zepto Life Technology wins $8.9m NIH contract for fungal infection panel
Zepto Life Technology secured an $8.9 million contract from the National Institute of Allergy and Infectious Diseases (NIAID) to advance its fungal infection diagnostic panel. The award follows the panel's FDA breakthrough device designation in June 2026, recognizing potential clinical advantages in rapid fungal pathogen identification.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network